Daniel W. Gil

2.1k total citations
29 papers, 1.5k citations indexed

About

Daniel W. Gil is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, Daniel W. Gil has authored 29 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 11 papers in Cellular and Molecular Neuroscience and 8 papers in Physiology. Recurrent topics in Daniel W. Gil's work include Receptor Mechanisms and Signaling (11 papers), Neuropeptides and Animal Physiology (7 papers) and Glaucoma and retinal disorders (6 papers). Daniel W. Gil is often cited by papers focused on Receptor Mechanisms and Signaling (11 papers), Neuropeptides and Animal Physiology (7 papers) and Glaucoma and retinal disorders (6 papers). Daniel W. Gil collaborates with scholars based in United States, Ireland and Czechia. Daniel W. Gil's co-authors include Barry B. Wolfe, E. Padillo, John E. Donello, David F. Woodward, John W. Regan, Larry A. Wheeler, Elizabeth WoldeMussie, Kristen L. Pierce, Jyotirmoy Kusari and Michelle Webster and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Gastroenterology.

In The Last Decade

Daniel W. Gil

29 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel W. Gil United States 22 865 421 372 238 194 29 1.5k
W.G. Unger United Kingdom 29 911 1.1× 736 1.7× 1.0k 2.8× 558 2.3× 563 2.9× 62 2.5k
Noriko Himori Japan 23 596 0.7× 738 1.8× 219 0.6× 75 0.3× 194 1.0× 94 1.6k
R. Canella Italy 11 637 0.7× 304 0.7× 630 1.7× 267 1.1× 186 1.0× 16 1.3k
Daniel A. Ryskamp United States 17 996 1.2× 233 0.6× 522 1.4× 146 0.6× 195 1.0× 20 1.5k
Akira Hirose Japan 19 375 0.4× 177 0.4× 353 0.9× 77 0.3× 83 0.4× 48 1.3k
Célia A. Aveleira Portugal 17 501 0.6× 240 0.6× 187 0.5× 48 0.2× 257 1.3× 28 1.3k
Paulo F. Santos Portugal 24 632 0.7× 379 0.9× 473 1.3× 41 0.2× 92 0.5× 45 1.3k
Alberto Pérez‐Mediavilla Spain 20 834 1.0× 58 0.1× 448 1.2× 228 1.0× 795 4.1× 39 1.7k
Bóglárka Rácz Hungary 27 912 1.1× 105 0.2× 885 2.4× 65 0.3× 141 0.7× 65 1.7k
Marcello Diego Lograno Italy 17 219 0.3× 120 0.3× 136 0.4× 130 0.5× 157 0.8× 50 739

Countries citing papers authored by Daniel W. Gil

Since Specialization
Citations

This map shows the geographic impact of Daniel W. Gil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel W. Gil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel W. Gil more than expected).

Fields of papers citing papers by Daniel W. Gil

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel W. Gil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel W. Gil. The network helps show where Daniel W. Gil may publish in the future.

Co-authorship network of co-authors of Daniel W. Gil

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel W. Gil. A scholar is included among the top collaborators of Daniel W. Gil based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel W. Gil. Daniel W. Gil is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gil, Daniel W., et al.. (2015). Role of sympathetic nervous system in rat model of chronic visceral pain. Neurogastroenterology & Motility. 28(3). 423–431. 23 indexed citations
2.
Lin, Chun Shi, Mark S. Sharpley, Weiwei Fan, et al.. (2012). Mouse mtDNA mutant model of Leber hereditary optic neuropathy. Proceedings of the National Academy of Sciences. 109(49). 20065–20070. 170 indexed citations
3.
Donello, John E., Yun Guan, Mingting Tian, et al.. (2011). A Peripheral Adrenoceptor-mediated Sympathetic Mechanism Can Transform Stress-induced Analgesia into Hyperalgesia. Anesthesiology. 114(6). 1403–1416. 44 indexed citations
4.
Piu, Fabrice, Luis R. Gardell, Andria L. Del Tredici, et al.. (2008). Broad modulation of neuropathic pain states by a selective estrogen receptor beta agonist. European Journal of Pharmacology. 590(1-3). 423–429. 35 indexed citations
5.
Gil, Daniel W., et al.. (2007). Transient allodynia pain models in mice for early assessment of analgesic activity. British Journal of Pharmacology. 153(4). 769–774. 10 indexed citations
6.
Woodward, David F. & Daniel W. Gil. (2004). The inflow and outflow of anti-glaucoma drugs. Trends in Pharmacological Sciences. 25(5). 238–241. 29 indexed citations
7.
Donello, John E., E. Padillo, Michelle Webster, Larry A. Wheeler, & Daniel W. Gil. (2001). α2-Adrenoceptor Agonists Inhibit Vitreal Glutamate and Aspartate Accumulation and Preserve Retinal Function after Transient Ischemia. Journal of Pharmacology and Experimental Therapeutics. 296(1). 216–223. 41 indexed citations
8.
Wheeler, Larry A., Daniel W. Gil, & Elizabeth WoldeMussie. (2001). Role of Alpha-2 Adrenergic Receptors in Neuroprotection and Glaucoma. Survey of Ophthalmology. 45. S290–S294. 81 indexed citations
9.
Schuster, Victor L., Steven W. Andrews, Robert M. Burk, et al.. (2000). Synthetic Modification of Prostaglandin F2αIndicates Different Structural Determinants for Binding to the Prostaglandin F Receptor Versus the Prostaglandin Transporter. Molecular Pharmacology. 58(6). 1511–1516. 24 indexed citations
10.
Kedzie, Karen M., et al.. (1998). A Single Amino-Acid Substitution in the EP2Prostaglandin Receptor Confers Responsiveness to Prostacyclin Analogs. Molecular Pharmacology. 54(3). 584–590. 28 indexed citations
11.
Pierce, Kristen L., Thomas J. Bailey, Patricia B. Hoyer, et al.. (1997). Cloning of a Carboxyl-terminal Isoform of the Prostanoid FP Receptor. Journal of Biological Chemistry. 272(2). 883–887. 87 indexed citations
12.
Gil, Daniel W., et al.. (1997). Muscarinic receptor subtypes in human iris-ciliary body measured by immunoprecipitation.. PubMed. 38(7). 1434–42. 83 indexed citations
13.
Woodward, David F., A M Bogardus, John E. Donello, et al.. (1995). Molecular Characterization and Ocular Hypotensive Properties of the Prostanoid EP 2 Receptor. Journal of Ocular Pharmacology and Therapeutics. 11(3). 447–454. 24 indexed citations
14.
Pierce, Kristen L., Daniel W. Gil, David F. Woodward, & John W. Regan. (1995). Cloning of human prostanoid receptors. Trends in Pharmacological Sciences. 16(8). 253–256. 68 indexed citations
15.
Chandraratna, Roshantha A.S., et al.. (1995). Synthesis and pharmacological activity of conformationally restricted, acetylenic retinoid analogs. Bioorganic & Medicinal Chemistry Letters. 5(5). 523–527. 10 indexed citations
16.
Huang, Yi, Daniel W. Gil, Patrick Vanscheeuwijck, W. Daniel Stamer, & John W. Regan. (1995). Localization of alpha 2-adrenergic receptor subtypes in the anterior segment of the human eye with selective antibodies.. PubMed. 36(13). 2729–39. 40 indexed citations
17.
Graves, P E, Kristen L. Pierce, Thomas J. Bailey, et al.. (1995). Cloning of a receptor for prostaglandin F2 alpha from the ovine corpus luteum.. Endocrinology. 136(8). 3430–3436. 51 indexed citations
18.
Gil, Daniel W. & Barry B. Wolfe. (1986). Muscarinic cholinergic receptor binding sites differentiated by their affinity for pirenzepine do not interconvert.. Journal of Pharmacology and Experimental Therapeutics. 237(2). 577–582. 5 indexed citations
19.
Gil, Daniel W. & Barry B. Wolfe. (1985). Pirenzepine distinguishes between muscarinic receptor-mediated phosphoinositide breakdown and inhibition of adenylate cyclase.. Journal of Pharmacology and Experimental Therapeutics. 232(3). 608–616. 197 indexed citations
20.
Gil, Daniel W., Spencer A. Brown, Steven H. Seeholzer, & Gary Wildey. (1983). I. Introduction Phosphatidylinositol turnover and cellular function. Life Sciences. 32(18). 2043–2046. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by W.G. Unger Breakdown of academic impact, for papers by Noriko Himori Breakdown of academic impact, for papers by R. Canella Breakdown of academic impact, for papers by Daniel A. Ryskamp Breakdown of academic impact, for papers by Akira Hirose Breakdown of academic impact, for papers by Célia A. Aveleira Breakdown of academic impact, for papers by Paulo F. Santos Breakdown of academic impact, for papers by Alberto Pérez‐Mediavilla Breakdown of academic impact, for papers by Bóglárka Rácz Breakdown of academic impact, for papers by Marcello Diego Lograno
Rankless by CCL
2026